Hutchinson-gilford Progeria Syndrome
📧 Sign up to get email alerts when something new happens for Hutchinson-gilford Progeria Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) [Phase 2]
A Phase 2 clinical trial update for Progerinin in Hutchinson-Gilford Progeria Syndrome to determine optimal dosing and assess safety, tolera…
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Umbilical Cord Blood Transfusion in Progeria Syndrome [Phase 1, Phase 2]
Phase 1/2 clinical trial on umbilical cord blood transfusion for Hutchinson-Gilford Progeria Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria [Phase 2]
Phase II trial of lonafarnib for Progeria (Hutchinson-Gilford Progeria syndrome) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid [Phase 2]
A Phase 2 clinical trial evaluating a combination of pravastatin and zoledronic acid for Hutchinson-Gilford Progeria Syndrome has completed,…